fda takes tirzepatide off shortage list Compounders lose battle over Eli Lilly weight loss drug and Tirzepatide OFF FDA shortage list.

Eli Lilly, a US company, manufactures Mounjaro, and Novo Nordisk, a Danish company, produces Ozempic

Priority review, granted for drugs addressing unmet medical needs, takes about 6 months

Zepbound Clinical Benefits Beyond Weight Loss: Liver and Joint Health In the most recent TRIUMPH-4 Phase 3 results (December 2025), Retatrutide demonstrated that its impact extends far beyond the number on the scale

Statistical analysis Landau et al

Provide the safest facial rejuvenation treatments to your patients As medically-supported weight loss becomes increasingly popular in the UK, knowing how best to help your patients is not only useful